Stroke Trial, Recruiting NCT06275516 Sponsor: First Affiliated Hospital of Chongqing Medical University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06275516
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been formally diagnosed with a stroke for the first time, confirmed according to standard diagnostic requirements
  • People whose lower limb movement after stroke is moderately to severely affected, based on a standard assessment score below 34 out of 34 (Fugl-Meyer Lower Extremity scale)
  • People aged between 18 and 85 years old
  • People who are able to walk with a small amount of assistance
  • People who score between 20 and 30 on a standard memory and thinking test (MMSE), and who are able to understand and follow instructions during the trial
  • People who are able to sign a consent form agreeing to take part

Who may not be able to join:

  • People with serious vision or hearing problems
  • People who are pregnant or breastfeeding
  • People who have had brain surgery and still have an unrepaired opening in the skull, or who have metal implants in the head from brain surgery
  • People who have other conditions that affect movement in the legs or feet, such as severe joint disease or a recent leg fracture
  • People with a history of serious mental health disorders, other brain or nervous system conditions, severe heart or lung problems, failure of multiple organs, brain tumours, or epilepsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dingqun Bai, First Affiliated Hospital of Chongqing Medical University

Phone: 023-89011334

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Chongqing Medical University
Registry
ClinicalTrials.gov
Start date
20 March 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Fugl-Meyer Assessment- Lower Extremity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov